Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Business models
Business models
B2B
Products 151 to 160 of 162
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Synthorin™ Protein
by
Synthorx
+
Scripps Research Institute
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
79,000,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
TALEN
by
Cellectis
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
+
France
Country of distribution:
USA
+
France
Intended consumer:
Research
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
17,400,000 EUR
Funding types:
Shareholder Investment
Industry:
Health
+
Multipurpose
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
Web search
Trading symbol:
CLLS, ALCLS
(NASDAQ, EPA)
Value chain stage:
Platform
TransFerm® Yield+
by
Mascoma
Biotech components:
Microbe
+
Fungus
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
179,800,000 USD
Funding types:
Venture Capital
Industry:
Industrial
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Transgenic Strawberry Plants
by
Hokkai Sankyo Company Ltd
Biotech components:
Gene Editing
+
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/01/21 15:00 (5 years ago)
Date last modified:
2020/01/21 15:00 (5 years ago)
Known funding amount:
N/A
Funding types:
Research Institution
Industry:
Medical
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Medicine
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Valencene
by
Isobionics
+
Allylix
+
Royal DSM
Biotech components:
Plant
Business models:
B2B
Country of production:
Netherlands
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Vanillin
by
Evolva
Biotech components:
Microbe
+
Fungus
Business models:
B2B
Country of production:
USA
Country of distribution:
Switzerland
+
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
Vitamin D2
by
Nucelis
Biotech components:
Plant
Business models:
B2B
+
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Health
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Personal Care (Ingested)
+
Food
Production process:
Open Release
Source:
N/A
Trading symbol:
N/A
Value chain stage:
Finished Product
Wild Type Salmon Meat
by
Wild Type
Biotech components:
Animal
Business models:
B2B
+
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/11/19 09:36 (7 years ago)
Date last modified:
2019/06/21 16:06 (6 years ago)
Known funding amount:
3,500,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Food
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Xylathin Xylanase (#1)
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2019/05/15 15:44 (6 years ago)
Known funding amount:
2,147,483,647 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Yeast based platform to synthesize complex bioactive molecules
by
Concordia University
Biotech components:
Yeast
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:38 (5 years ago)
Date last modified:
2020/12/18 14:38 (5 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
+
Multipurpose
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medicine
+
Other
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Platform
1
…
8
9
10
11
12
13
14
15
16
17
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
